Senate “BioShield II” Hearing Postponed
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate Health Committee will reschedule a hearing on the "Project BioShield II" legislation planned for Sept. 8
You may also be interested in...
Senate "BioShield II" Hearing To Discuss Manufacturer Liability, Development Incentives
Joint Health-Judiciary Committee hearing Oct. 6 will review additional incentives for pharmaceutical and biotech firms to develop medical countermeasures for bioterrorism-related threats.
Senate "BioShield II" Hearing To Discuss Manufacturer Liability, Development Incentives
Joint Health-Judiciary Committee hearing Oct. 6 will review additional incentives for pharmaceutical and biotech firms to develop medical countermeasures for bioterrorism-related threats.
Senate “BioShield II” Hearing On Incentives Slated Tentatively For Oct. 6
The joint Senate HELP-Judiciary hearing will include representatives from small and large companies and feature discussion on greater funding and stronger liability protections than are included in the existing BioShield law.